Advertisement
Advertisement

OPRX

OPRX logo

OptimizeRx Corporation Common Stock

7.98
USD
Sponsored
+0.03
+0.38%
Aug 31, 15:59 UTC -4
Closed
exchange

After-Market

7.97

-0.01
-0.06%

OPRX Earnings Reports

Positive Surprise Ratio

OPRX beat 31 of 38 last estimates.

82%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$22.54M
/
$0.22
Implied change from Q2 26 (Revenue/ EPS)
+9.93%
/
+37.50%
Implied change from Q3 25 (Revenue/ EPS)
-13.53%
/
+10.00%

OptimizeRx Corporation Common Stock earnings per share and revenue

On Aug 12, 2026, OPRX reported earnings of 0.16 USD per share (EPS) for Q2 26, beating the estimate of 0.11 USD, resulting in a 33.44% surprise. Revenue reached 20.50 million, compared to an expected 20.61 million, with a -0.50% difference. The market reacted with a +24.72% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of 0.22 USD, with revenue projected to reach 22.54 million USD, implying an increase of 37.50% EPS, and increase of 9.93% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Intuit Inc
Report Date
Aug 25, 2026 For Q4 26
Estimate
$3.65
Actual
$4.03
Surprise
+10.31%
logo
Synopsys Inc
Report Date
Aug 26, 2026 For Q3 26
Estimate
$3.73
Actual
$3.91
Surprise
+4.56%
FAQ
For Q2 2026, OptimizeRx Corporation Common Stock reported EPS of $0.16, beating estimates by 33.44%, and revenue of $20.50M, -0.5% below expectations.
The stock price moved up 24.72%, changed from $7.04 before the earnings release to $8.78 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 9 analysts, OptimizeRx Corporation Common Stock is expected to report EPS of $0.22 and revenue of $22.54M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement